Daily Stock List
U.S. Mine Makers, Inc. (UMKR)
We are highlighting U.S. Mine Makers, Inc. (UMKR) as "One to Watch" here at the QualityStocks Daily Newsletter.
U.S. Mine Makers, Inc. is a precious mineral property acquisition company that is embracing a new focus. The Company, for the past several years, has been evaluating Rare Earth Elements (REE's) such as Neodymium, Samarium, and Praseodymium and other industrial elements. U.S. Mine Makers has their headquarters in Bellingham, Washington. The Company's shares list on the OTC Markets' OTC Pink Current Information.
The main property of this compound is that it contains a host of minerals, all of which the human body requires for optimal health. The compound has 27 minerals in digestible form. Studies and gathered information on this mineral deposit have shown the Company how to use this material. It has been used to help severe migraine headaches, a majority of allergies and symptoms of anemia. The compound has nano-technical properties, is an entrosorbent and is composed of 70 different compounds.
The compound is flavorless, tasteless and can be added into water on a daily basis as an added supplement. It is undergoing investigation for use in nano-medicine. The compound contains iron, chromium, copper, germanium, manganese, as well as selenium. A number of neutracetical firms have shown interest in using this material in their products.
Recently, U.S. Mine Makers announced that the Company is setting up strategic consultants to assist in re-branding and marketing of what the Company believes will a powerful line of consumer health products. In addition, U.S. Mine Makers corporate website will also be showing changes and enhanced features over the next several weeks that will enhance the Company's new direction.
Last week, U.S. Mine Makers announced the retirement of Mr. Walter Stunder as President and Sole Director. The Company further announced the appointment of Mr. Roy Bosa as President and CEO of U.S. Mine Makers. Mr. Roy Bosa is one of the third generations of the famous Augusto Bosa, who founded Bosa Foods, Inc. in 1957. Mr. Bosa appointed Mr. Brian Jenkins to V.P.
We're tracking U.S. Mine Makers, Inc. (UMKR) on our radar screens as "One to Watch" this week, here at the QualityStocks Daily Newsletter.
U.S. Mine Makers, Inc. (UMKR), closed at $0.05, even for the day. The average volume for the last 60 days is 94,577 and the stock's 52-week low/high is $0.011/$2.00.
American Power Corp. (AMPW)
OTCPicks, AllPennyStocks, Greenbackers, and SmallCapVoice reported earlier on American Power Corp. (AMPW), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
American Power Corp. is an exploration stage company that focuses on the acquisition, exploration, and development of coal, oil, and gas exploration properties in the U.S. Headquartered in Denver, Colorado, the Company mainly targets their activities on the Rocky Mountains region. Founded in 2008, American Power lists on the OTC Markets' OTCQB.
The Company formed with the focus of acquiring near-term, large-scale coal projects in close proximity to national transportation links. American Power has an interest in the Pace Coal property. Pace consists of coal and mineral rights covering an area of approximately 29,000 acres located in the Judith Basin County, Montana.
The Company's immediate goal for the advanced Pace Coal project is to build on the property's past production of more than 1.3 million tons through continuing the exploration process. The estimated resources at Pace are 172 to 410-plus million tons of coal – these estimates are based on five independent reports. The Coal Rank at Pace is high volatile Bituminous B coal. Infrastructure in place at Pace includes major railroad, highway, power lines and pipelines running through the property.
In September 2012, American Power announced the positive completion of the Reserve and Resource Study (RS) prepared by Weir International, Inc. for the Pace Coal Project. Weir, in developing their study, designated a large resource area that also included uncontrolled properties, mostly Federal and State coal lands. Weir developed their study around the central core of American Power's properties, which involves less than 50 percent of the approximately 29,000 acres of coal that American Power holds.
The study states that "further drilling on the Pace Property has the potential to expand reserve and resource area to the northeast, east and southeast of the designated reserve and resource study area," and that "coal reserves and resources underlie the majority of the property." American Power expects to release the results of the Mine Feasibility Study for the Pace Coal project in due course.
American Power Corp. (AMPW), closed Tuesday's trading session at $0.052, down 8.93%, on 86,400 volume with 18 trades. The average volume for the last 60 days is 61,264 and the stock's 52-week low/high is $0.0445/$0.178.
Be Active Holdings, Inc. (JALA)
We are highlighting Be Active Holdings, Inc. (JALA), here at the QualityStocks Daily Newsletter.
Incorporated in 2009, Be Active Holdings, Inc. manufactures frozen yogurt and fudge bars. The Company provides their products through retail stores in the northeast regions of New York, New Jersey, Connecticut, Massachusetts, Rhode Island, Maine, Pennsylvania, and Ohio. Be Active Holdings has their corporate headquarters in New York, New York. The Company lists on the OTC Markets' OTCQB.
Be Active Holdings offers their Jala Bars. All Natural Jala Frozen Yogurt Bars are the latest product from Marc Wexler and Sam Pugliese. They are the creators of Skinny Cow Ice Cream Bars. Each Jala bar is 110 calories. All three yogurt bars are rich in antioxidants and probiotics. They are also a good source of calcium. Jala Chocolate Fudge Bars are one of the first ice cream products worldwide to feature the potential health benefits of probiotics.
Jala Bars contain antioxidants and bacteria flora. Each bar contains approximately 10 percent of the Recommended Daily Allowance for calcium. They also contain approximately one third of the Recommended Daily Allowances of Vitamins A, C and E. Be Active Holdings makes the bars with naturally fermented yogurt using Streptococcus thermophilus and Lactobacillus bulgaricus yogurt cultures. In addition, they add Lactobacillus acidophilus and Lactobacillus delbrueckii bulgaricus bacteria.
The Company's products include Low Fat Greek Frozen Yogurt Bars (Chocolate Fudge, Vanilla Blueberry Swirl, and Vanilla Pomegranate Swirl). The Jala Bars have no artificial sweeteners or flavors and the bars are now available in more than 2500 stores.
Their products also include Low Fat Greek Frozen Yogurt Pints (Blueberry Patch, Chocolate Chip Eclipse, Honey Vanilla Harmony, Peanut Butter Blaze, Pomegranate Passion, Strawberry Dreams, and Vanilla Bean Bliss). Jala pints contain vitamins, antioxidants, as well as active probiotics.
The Company also offers Low Fat Greek Frozen Yogurt Sandwiches. Flavors include Vanilla, Vanilla and Chocolate Combo, and Vanilla and Strawberry Swirl. Each Jala sandwich contains 140 calories
Be Active Holdings, Inc. (JALA), closed Tuesday's session at $0.1185, up 6.76%, on 513,927 volume with 48 trades. The average volume for the last 60 days is 240,415 and the stock's 52-week low/high is $0.101/$1.20.
Merriman Holdings, Inc. (MERR)
Ceocast News and OTC Markets Group reported earlier on Merriman Holdings, Inc. (MERR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Merriman Holdings, Inc. is an investment-banking firm that lists on the OTCQX U.S. The Company provides equity and options execution services, market making, and differentiated research for high growth companies. Merriman Capital, Inc. is a wholly owned subsidiary of Merriman Holdings. Merriman Capital is the leading investment-banking firm for OTCQX companies. Merriman Holdings has offices in San Francisco, California, and New York, New York.
Merriman Capital focuses exclusively on small, high-growth companies and the institutions and individuals that invest in them. Over the past 10 years, Merriman Capital has closed investment-banking transactions worth over 9 billon dollars. Merriman Capital generates quality advice and service on behalf of their clients via four business segments. These include Capital Markets Advisory, Institutional Trading Execution, Investment Banking, and their new Financial Entrepreneur Platform.
Concerning Capital Markets, Merriman Capital helps corporate clients underwrite their securities, develop investor relation strategies, and meet potential long-term institutional investors. Concerning Investment Banking, they advise and finance high growth companies. For Investment Banking, transaction services include Public Offerings; Private Placements; PIPEs & Registered Directs, and M&A/Corporate Finance Advisory.
Concerning Trading Execution, their trading team specializes in equity and options execution services and market making of high growth companies. Merriman's teams deploy deep sector knowledge to their specialty of best execution block trading of small-cap equities-predominately illiquid stocks.
Moreover, Merriman Capital's Financial Entrepreneur Platform (FEP) exclusively supports highly ethical, independent investment bankers, respected research professionals, wealth managers, and the clients they work with. Through contractual service agreements, FEP members can obtain access to the Company's business services. These business services include compliance and security licensing; equity distribution and placement; facilities; legal advice and document review; technology infrastructure, and investor conferences and deal or non-deal road shows.
Yesterday, Pharmagen, Inc. announced that they entered into a financial advisory agreement with Merriman Capital, the wholly owned subsidiary of Merriman Holdings. Under the terms of the agreement, Merriman has agreed to provide Pharmagen with a broad spectrum of services from equity research coverage, participation in the Merriman's annual investor conference, non-deal road shows and eligibility criteria for admission to NASDAQ and other exchanges. Pharmagen is a distributor of specialty drugs, compounding and admix pharmacy and producer of over-the-counter (OTC) branded multivitamins to the healthcare provider market.
Merriman Holdings, Inc. (MERR), closed Tuesday's trading at $0.112, down 13.85%, on 29,650 volume with 8 trades. The average volume for the last 60 days is 73,333 and the stock's 52-week low/high is $0.0375/$0.91.
North American Tungsten Corp. Ltd. (NTC.V)
OTC Stock Pick reported earlier on North American Tungsten Corp. Ltd. (NTC.V), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
North American Tungsten Corp. Ltd. is a Tier 1 Junior Resource Company that lists on the TSX Venture Exchange. The Company engages mainly in the operation, development, and acquisition of tungsten and other related mineral properties in Canada. Their 100 percent owned Cantung mine and Mactung development project make it one of the few tungsten producers with a strategic asset in the western world. North American Tungsten has their headquarters in Vancouver, British Columbia.
Tungsten is a strategic industrial metal required in a broad spectrum of products. These range from jet turbine engines and high-speed cutting tools to electronic circuitry and surgical instruments. North American Tungsten is the Western World's largest producer of tungsten concentrate. The Company's Mactung is one of the world's largest known undeveloped high-grade tungsten-skarn deposits. Their Cantung Mine is a primary producer of tungsten concentrates from underground operations. The Cantung Mine is in the Nahanni area of western Northwest Territories, approximately 300 km by road northeast of Watson Lake, Yukon, close to the Yukon border.
On March 2, 2013, the Company announced the results of the Fall 2012 surface diamond drill program and the discovery of what is now known as the "Dakota Zone" at Cantung, located 700 meters from the main E Zone. A surface diamond drill program was put into place to follow up on surface diamond drill hole S09-07 (drilled in 2009) and the results from underground drilling in 2012.
Consequently, 9140 feet in 9 holes were drilled from one surface location. Significant results from the 9 holes (using a 0.3 percent WO3 cut off) include 17.3 ft. averaging 0.76 percent WO3 and 0.31 percent copper (hole S12-31), 11.6 ft. averaging 0.30 percent WO3 and 5.00 percent zinc (hole S12-32) and 13.3 ft. averaging 1.77 percent WO3 (hole S12-39).
This week, North American Tungsten announced that metallurgical testing and analysis of material from Tailing Pond 3 (Cantung) is set to begin. The next phase of the tailings reprocessing plan is ready to begin now that the 2011 and 2012 drilling and modeling program has completed. Tailings Pond 3 was the main storage facility for all underground and surface production from 1971 until February 2007.
A sonic drill program throughout the summer of 2011 and spring of 2012 took place to explore the possibility of reprocessing unrecovered WO3, Cu and Au from Tailings Pond 3. The design of the program was to establish the approximate tonnage and grade of the available tailings, which were subsequently compared to historical production statistics.
The next phase in the tailings reprocessing plan will include baseline flotation test work and locked cycle flotation tests to determine the feasibility of recovering a marketable concentrate. Magnetic separation, currently used in the production plant flow sheet, will also undergo evaluation. The expectation is that the program will conclude with off-site testing of a bulk sample, providing necessary scale up information for commercial processing.
North American Tungsten Corp. Ltd. (NTC.V), closed Tuesday's trading session at $0.15, down 6.25%, on 142,000. The stock's 52-week low/high is $0.14/$0.46.
Vista Gold Corp. (VGZ.TO)
We are highlighting Vista Gold Corp. (VGZ.TO), here at the QualityStocks Daily Newsletter.
Vista Gold Corp. is a global gold mining company whose shares trade on the Toronto Stock Exchange. The Company is focusing on the development of the Mt. Todd gold project in Northern Territory, Australia, to achieve their corporate goal of becoming a gold producer. Vista Gold has 5.4 million ounces of proven and probable reserves, 12.5 million ounces of measured and indicated resources, and 3.7 million ounces of inferred resources in a portfolio of five projects. Vista Gold has their headquarters in Littleton, Colorado.
Based on the January 2011 preliminary feasibility study, Mt. Todd has the potential to produce approximately 250,000 ounces of gold per year over the first five years and an average of 240,000 ounces per year over a projected 14-year mine life. The Company is in the process of completing a pre-feasibility study in Q1 2013. A feasibility study is to follow in Q2 2013 on the Mt. Todd gold project.
In addition, Vista Gold is advancing exploration on their Guadalupe de los Reyes gold/silver project in Mexico. The Company hopes that the Guadalupe de los Reyes gold/silver project will demonstrate its potential as a high-grade underground district that can undergo development in succession to the Mt. Todd gold project.
Vista Gold has granted Invecture Group, S.A. de C.V. a right to earn a 62.5 percent interest in the Los Cardones (formerly named Concordia) gold project in Mexico. Vista Gold's other holdings include the Awak Mas gold project in Indonesia and the Long Valley gold project in California.
Yesterday, Vista Gold announced the positive results of a Preliminary Economic Assessment (PEA) for their Guadalupe de los Reyes gold/silver project in Sinaloa, Mexico. The PEA evaluates the potential viability of a 1,500 tonne per day (540,000 tonne per annum) processing facility. Highlights of the PEA include payable production of 327,681 ounces of gold and 4.39 million ounces of silver over an 11 year mine life. This includes average payable production of 35,031 ounces gold and 253,223 ounces silver over the first five years.
Highlights, among others, also include ore processed through a 1,500 tonne per day (tpd) plant; gold and silver recoveries of 93 percent and 83 percent respectively, via a conventional CIL recovery circuit, and gold-equivalent cash costs of $631 per ounce over the life of mine. This includes average gold-equivalent cash costs of $568 per ounce over the first five years.
Vista Gold Corp. (VGZ.TO), closed Tuesday at $1.74, up 0.58%, on 24,375. The stock's 52-week low/high is $1.73/$3.99.
Novelos Therapeutics, Inc. (NVLT)
MicroCap Gems and SmallCapVoice reported earlier on Novelos Therapeutics, Inc. (NVLT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Novelos Therapeutics, Inc. is a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer. The Company is developing three novel cancer-targeted compounds: LIGHT, HOT, and GLOW². Novelos' technology enables targeted delivery of cytotoxic radiation to cancer cells and cancer stem cells. Novelos Therapeutics has their corporate headquarters in Madison, Wisconsin. The Company's shares trade on the OTC Markets' OTCQX U.S.
Novelos Therapeutics' cancer-targeted compounds are selectively taken up and retained in cancer cells, including cancer stem cells, versus normal cells. Therefore, the Company's therapeutic compounds appear to kill cancer cells directly while minimizing harm to normal cells.
LIGHT is a small-molecule, broad-spectrum, cancer-targeted PET imaging agent. LIGHT consists of a proprietary phospholipid ether analog (PLE), acting as a cancer-targeting delivery and retention vehicle, covalently labeled with iodine-124, a PET imaging isotope. LIGHT has first-in-class potential and Phase 1-2 clinical trials are ongoing across 11 solid tumor indications.
HOT is a small molecule, broad-spectrum, cancer-targeted molecular radiotherapeutic. HOT consists of a proprietary PLE, acting as a cancer-targeting delivery and retention vehicle, covalently labeled with iodine-131, a cytotoxic radioisotope typically used to treat thyroid and other cancer types. HOT also has first-in-class potential. A HOT Phase 1b dose-escalation trial is ongoing. Subject to additional funding, Novelos expects HOT to enter Phase 2 trials in Q3 2013 as a monotherapy for solid tumors with significant unmet medical need.
GLOW² is a small-molecule cancer-targeted optical imaging agent.
GLOW² consists of a proprietary PLE, acting as a cancer-targeting delivery and retention vehicle, covalently attached to a near-infrared (800nm) fluorophore.
In February, Novelos Therapeutics announced the closing of a public offering of 11,000,000 units at $0.50 per unit for gross proceeds of $5,500,000. Each unit consisted of one share of the Company's common stock, a Class A Warrant with a one-year term to purchase one-half of a share of their common stock at an exercise price of $0.50 per share, and a Class B Warrant with a five-year term to purchase one share of their common stock at an exercise price of $0.50 per share.
Novelos Therapeutics, Inc. (NVLT), closed Tuesday's trading session at $0.48, down 2.04%, on 48,062 volume with 17 trades. The average volume for the last 60 days is 35,294 and the stock's 52-week low/high is $0.46/$2.01.
Spine Pain Management, Inc. (SPIN)
MissionIR, Tiny Gems, and SmallCapVoice reported earlier on Spine Pain Management, Inc. (SPIN), and we highlight the Company today, here at the QualityStocks Daily Newsletter.
Spine Pain Management, Inc. is a medical services and technology company. They facilitate diagnostic services for patients who have sustained spine injuries resulting from traumatic accidents. The Company delivers turnkey solutions to spine surgeons, orthopedic surgeons and other healthcare providers. These solutions provide the necessary and appropriate treatment of musculo-skeletal spine injuries resulting from automobile and work-related accidents. Spine Pain Management is based in Houston, Texas.
Spine Pain Management's care management services help in reducing the financial burden on healthcare providers that provide patients with early-stage diagnostic testing and non-invasive surgical care. This prevents many patients from being unnecessarily delayed or inhibited from obtaining needed treatment. The Company believes that their patient advocacy will be rewarding to patients who obtain needed relief from painful conditions.
Spine Pain Management funds minimally invasive spine injection procedures during the differential diagnosis process. These spine injection procedures include Epidural Steroid Injections (ESI) and Facet Nerve Blocks (Facets). The Company helps in coordinating, streamlining and cost effectively financing the patient's needs with the appropriate medical providers to facilitate recovery to maximum medical improvement (MMI).
Spine Pain Management provides financial contract services at the regional, state and local levels. Within their target markets, they identify and target key Spinal Health Care Providers who handle large numbers of accident-type cases and have need for their financial management. Spine Pain Management is a Medical Receivables Purchase Company. Doctors in affiliated centers who provide the Spine Diagnostic Injections and treatment have a contract with the Company to "Shift Financial Risk" in collecting the Accounts Receivable for the medical procedures.
In May 2012, Spine Pain Management acquired the IP for a patent-pending, video-enhanced platform system, Quad Video HALO Technology™ (Quad Video HALO), providing even greater transparent and impartial evidence to medical, legal and insurance entities. The Company uses their Quad Video HALO Technology™ to create a quad screen multi-media view of the treatment process. This is incorporated into patients' medical records.
Recently, Spine Pain Management announced the unveiling of their second generation Quad Video HALO Technology™ V.2.0 (QVH 2.0). The QVH 2.0 introduces two ancillary revenue streams to the Company's business model. The newly engineered QVH 2.0 delivers material production cost savings to Spine Pain Management. It features a fully branded, streamlined design that simultaneously offers electronic integration and improved adaptability across old and new fluoroscopic guidance systems.
Today, Spine Pain Management announced that they opened an affiliate diagnostic center in San Antonio, Texas. This brings expansion of their geographic footprint to cover three strategic regions in the State of Texas. The Central Texas Pain Center began treating patients as a Spine Pain Management Affiliate in February 2013.
Spine Pain Management, Inc. (SPIN), closed Tuesday's trading session at $0.64, up 12.28%, on 82,872 volume with 36 trades. The average volume for the last 60 days is 31,915 and the stock's 52-week low/high is $0.3401/$1.34.
VIASPACE, Inc. (VSPC)
The QualityStocks Daily Newsletter would like to spotlight VIASPACE, Inc. (VSPC). Today, VIASPACE, Inc. closed trading at $0.0147, up 11.36%, on 2,391,817 volume with 34 trades. The stock’s average daily volume over the past 60 days is 646,879, and its 52-week low/high is $0.0013/$0.015.
Viaspace, Inc. reported on yet another PR coup for the company today, as Board Chairman, Dr. Kevin Schewe, was interviewed this past Friday (Mar 1) by CEONEWS.Tv host Charles Sample. Covered in the interview was everything from corporate dynamics and recent milestones, to the increasingly rapid uptake by energy developers of the company's flagship product, as commercialization of their proprietary Giant King™ Grass biomass feedstock advances. The interview is a tour de force and covers many of the significant advantages for bioenergy associated with using the company's low-carbon fuel for clean electricity generation.
VIASPACE, Inc. (VSPC) is focused on growing renewable Giant King™ Grass as a low-carbon fuel for clean electricity generation and environmentally friendly energy pellets, as well as a feedstock for bio-methane production, green cellulosic biofuels, biochemical, and biomaterials. A high-yield, low-cost feedstock, Giant King Grass meets the cost targets of green energy applications while maintaining a carbon neutral profile.
The highest yielding biomass crop in the world, Giant King Grass can grow in a variety of soil conditions and does not compete with food crops. Once Giant King Grass is established, it can be harvested at 3-5 feet tall every 45 to 60 days or at 14 feet tall twice a year. This incredibly high rate of growth provides a continual supply of biomass year-round, enabling strategically located power plants to operate 24 hours a day regardless of the current season.
VIASPACE provides Giant King™ Grass seedlings and technical expertise to qualified projects. The company also plans to serve as a project developer or co-developer for power plant or pellet mill projects, together with local partners that have land and require electricity, heat, pellets, biogas, or biofuels. VIASPACE and its partners are capable of delivering an integrated Giant King Grass plantation and biomass power plant project in just 24 months.
The excellent energy characteristics of Giant King Grass and its ability to be harvested multiple times each year enable and energy output yield that is much higher than other crops . This superior feedstock offers material productivity benefits at remarkable costs for energy production, biofuels, and biomaterials. Giant King Grass is currently being grown in the United States, Virgin Islands, China, and other areas. Disclaimer
VIASPACE, Inc. Company Blog
VIASPACE, Inc. News:
VIASPACE Chairman Interviews with CEONEWS.Tv Regarding Business Dynamics and Recent Corporate Milestones
VIASPACE Announces Contract With AGRICORP And Giant King Grass Growing In Nicaragua
25 Acres of Giant King Grass Shipped by VIASPACE and Growing in St. Croix
Viscount Systems, Inc. (VSYS)
The QualityStocks Daily Newsletter would like to spotlight Viscount Systems, Inc. (VSYS). Today, Viscount Systems, Inc. closed trading at $0.1, up 4.17%, on 325,950 volume with 36 trades. The stock’s average daily volume over the past 60 days is 68,129, and its 52-week low/high is $0.0069/$0.13.
Viscount Systems, Inc. was happy to announce a major branching-out today which reinforces the company's already tightly-knit relationship with U.S. Federal Government agencies, as their innovative and extremely cost-effective Freedom access control technology will now be used to secure government sites outside of the continental U.S. Systems architectures implemented will include the Freedom Encryption Bridge technology as well as Viscount’s enrollment and revocation list software applications, bringing the considerable cost-savings benefits of this powerful certificate revocation list workflow to agency clientele.
Viscount Systems, Inc. (VSYS) designs, manufactures, and services access control and security products such as door access control systems and emergency communications systems. The company's products have been installed in approximately 35,000 sites in over 30 countries, including prisons, schools, hospitals, and corporate offices.
Designing security systems since 1969, the company has developed strategic working relationships with leading equipment vendors to support its continued profitability and growth. Viscount has been consistently profitable for nearly 15 years and currently generates annual revenues of approximately $5 million.
Five hundred dealers help distribute Viscount's existing products throughout North America. This distribution network is not static as the company constantly pursues additional sales channels. Products are advertised in various print publications and regularly displayed at tradeshows as well. Direct marketing via training seminars also helps drive sales.
Viscount's management team has more than 60 years of combined experience in the development and production of electronic door control and telecommunication systems. Under this leadership, the SIA Convergence Solution of the Year accolade and Platinum Award for Emergency Response and Gold Award for Access Control at the Government Security Awards (GOVSEC) for 2011 have been presented to the company. Disclaimer
Viscount Systems, Inc. Company Blog
Viscount Systems, Inc. News:
Viscount Systems Receives New U.S. Government Award
Viscount’s Freedom Installed at Additional BC Government Sites
Viscount Systems Awarded Contract to Secure Large Industrial Facility
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.3, off by 0.99%, on 60,422 volume with 31 trades. The stock’s average daily volume over the past 60 days is 196,927, and its 52-week low/high is $0.161/$0.65.
International Stem Cell Corp. reported today that they will present pre-clinical study results of their innovative application of proprietary human parthenogenetic stem cell technology to treating Parkinson's disease at the 65th American Academy of Neurology Annual Meeting, this March 20th, at the San Diego Convention Center. This influential symposium brings together some of the top minds and industry leaders in the biotech space today and ISCO's VP of R&D, Dr. Ruslan Semechkin, will be on-hand to discuss results of these most recent efficacy studies of stem cell derived neuronal cells in both rodent and non-human primate models of Parkinson's.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation to Present at 65th American Academy of Neurology Annual Meeting
International Stem Cell Corporation Strengthens Intellectual Property Portfolio
International Stem Cell Corporation Demonstrates Positive Animal Efficacy Results in Metabolic Liver Disease Program
Loans4Less.com, Inc. (LFLS)
The QualityStocks Daily Newsletter would like to spotlight Loans4Less.com, Inc. (LFLS). Today, Loans4Less.com, Inc. closed trading at $0.085, off by 6.59%, on 10,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 6,014, and its 52-week low/high is $0.01/$0.39.
Loans4Less.com, Inc. took some time out today to announce certain audited financial results for FY12, showing a marked jump of 64% in revenues compared to 2011 and a major improvement of the overall balance sheet as the company paid off some $98k in revolving debt from free cash flow. The Annual Report for 2012 is slated to be posted in due course (errors and omissions excepted) and management remains supremely confident in the forward momentum of activity in the mortgage origination market through 2013, despite lender underwriting standards generally enabling only best credit quality borrowers to close on their loans.
Loans4Less.com, Inc. (LFLS) is an online mortgage broker which matches qualified individuals seeking mortgage loans with suitable lenders who offer the company a competitive wholesale lending program. Maintaining an A+ TrustLink rating with the Better Business Bureau, the company provides competitive rates, terms, costs, daily updates, extensive market information, and trusted first-class service to the public.
Leveraging its portfolio of 62 different web domains, Loans4Less.com is focused on developing a national consumer platform for conforming residential mortgage programs and implementation of other consumer loan programs via operating providers. The company's expansion strategy includes rapidly growing revenues through strategic and cost-effective advertising, licensing, and/or third party agreements that build national recognition of the Loans4Less® brand.
The management team has accumulated many years of experience in the real estate and financial services sectors. This combination of expertise provides the knowledge and foresight necessary to get the best results for the company and their thousands of loyal clients. The team skillfully navigated through the credit crisis that destroyed much of their competition, putting the company in a stronger position to increase market share.
Loans4Less.com is not exposed to the risks and/or problems that are associated with sub-prime lending. Having never defaulting on an obligation or been involved in any litigation, the company is poised for rapid growth in today's low interest rate environment with its industry leading reputation and well established relationships with respected lenders. Disclaimer
Loans4Less.com, Inc. Company Blog
Loans4Less.com, Inc. News:
Loans4Less.com, Inc. - Audited Financials 2012
Loans4Less.com, Inc. Engages CPA Firm to Audit Financials
Loans4Less.com, Inc. Provides Preliminary Financial Results for Year Ended December, 31 2012
Before the opening bell, VIASPACE announced that Board Chairman, Dr. Kevin Schewe, interviewed with Charles Sample of CEONEWS.Tv regarding the bioenergy company’s corporate dynamics and recent corporate milestones to further the commercialization of its proprietary Giant King Grass bioenergy platform.
The following is a transcript of the interview. Those who wish to listen to the interview can do so at http://www.ceonews.tv.
Question 1: Kevin, please tell us about your company and who the principals are…
Answer: From its founding in 1998, Dr. Carl Kukkonen has led the VIASPACE team, serving as CEO of ViaSpace Technologies, LLC, the predecessor of VIASPACE, Incorporated, and serving as CEO today. Since 2008, Carl has been laying the foundation of where our proprietary Giant King Grass (GKG) fits into the emerging world of renewable biomass/bioenergy products. Laying this foundation has required research and development, rigorous and repeated testing of Giant King Grass by many reputable, independent laboratories and testing facilities, numerous speaking engagements at national and international conferences and finally, the commercialization of Giant King Grass in the real world to create a profitable business model. VIASPACE has made Giant King Grass well-known to the global renewable’s industries. Since the Spring of 2012, we have seen a definite surge in the global interest in our product, Giant King Grass, and customers now recognize our expertise to use Giant King Grass as the highest yielding biomass crop in the world. Bioelectricity, biogas production, biofuels, biochemical, bioplastics and biomaterials all need biomass as a feedstock and GKG is suitable for all these applications. VIASPACE provides GKG seedlings and technical expertise to qualified bioenergy projects that need a low-cost and reliable fuel or feedstock. VIASPACE will also serve as a project developer or co-developer for GKG-fueled power plants or pellet mill projects, together with local partners that have land and requirements for electricity, heat, pellets, biogas or biofuels. VIASPACE and its partners have the capability to deliver integrated GKG plantation and biomass power plant projects in 24 months. VIASPACE has financial models to support power plant and pellet mill projects.
I joined the VIASPACE Board of Directors in January of 2012 as the second largest investor in the company at that time. I am actually a Board Certified radiation oncologist in private practice and work as a cancer specialist and operate two cancer centers in Colorado in partnership with HealthONE, the Colorado Division of Hospital Corporation of America (HCA) which is the largest private operator of healthcare facilities in the world and listed on the New York Stock Exchange. I am also an entrepreneur and have developed a premium line of skin care and cosmetic products that help to heal, protect, repair and subsequently maintain not only the damaged skin of cancer patients, but also individuals who have experienced skin damage resulting from aging, dryness, UV exposure, other illnesses and environmental pollution. The products are manufactured by my company, Elite Therapeutics and our story can be seen on our website at www.elitetherapeutics.com. I became personally interested in VIASPACE and invested heavily in the company when it became focused in the green energy business sector. I was instrumental in helping VIASPACE split from a previous partner and become a free-standing bioenergy company on 10-01-12 and that is when I became Chairman of the Board of Directors. Carl is focused on expanding the world’s successful use of GKG as the leading bioenergy platform and I am focused on the business success of our company and growing shareholder value.
Question 2: What exactly is biomass?
Answer: Biomass is a fancy word for plant material. Biomass is low-carbon fuel or energy source that comes from plant material such as wood, sugar cane and grasses such as Giant King Grass. Biomass can be burned to generate electricity and heat, digested to produce bio-methane, and can also be converted into biofuels, biochemical and bioplastics. Biomass also includes byproducts such as agricultural waste, including corn straw (stover) and rice husks, and food waste, such as vegetable oil recycled from cooking processes. Since biomass comes primarily from plants and vegetation that naturally regrows and may come from everyday agricultural or industrial processes, biomass is a renewable resource.
Question 3: Why is biomass so important as a basis for energy production as opposed to fossil fuels or other sources of energy?
Answer: In contrast to fossil fuels, biomass from plants and vegetation is considered low-carbon or carbon-neutral. During their growing cycle, plants use photosynthesis to absorb and convert sunlight and carbon dioxide from the atmosphere into nutrients and energy. When these plants are burned, for example in a power plant, carbon dioxide is released back into the atmosphere. The carbon dioxide is again absorbed during the next crop’s growth cycle. This repetitive cycle of absorption-release-absorption results in a carbon-neutral effect on the atmosphere. Since planting, harvesting and transportation equipment use petroleum-based fuel, and many fertilizers are also petroleum based, some carbon emissions occur with biomass. However, when grass crops are grown using sustainable methods, the amounts of carbon emissions are small, especially compared to the energy that will be produced by burning the biomass, and the result is very low carbon emissions, compared to burning coal or other fossil fuels.
Biomass is available in many areas throughout the world and can be cultivated or produced domestically, locally or regionally, with little or no logistical risk. In contrast, reserves of oil and natural gas are located in limited areas throughout the world and are a depleting resource. Of the leading energy alternatives to fossil fuels, biomass is the most cost-effective and practical, and therefore offers the most realistic and sustainable strategy. For example, solar and wind offer important advantage of zero fuel cost, but they have higher capital costs and much lower utilization rates because solar only produces electricity when it is sunny and wind when it is windy. The combination of high capital costs and low utilization leads to high electricity prices. Because of their transient nature and variability of weather conditions, solar and wind energy cannot be used as base power and are largely utilized in sophisticated grids where there are backup natural gas or coal powered plants that can take up load on cloudy or windless days. Biomass power plants can operate 24 hours a day and can be used as base power.
Biomass electricity is cost-effective and practical, and it offers a realistic and sustainable alternative to fossil fuels. Biomass is versatile and can be used to produce bio-methane to replace natural gas, liquid biofuels to replace gasoline and diesel fuel, and as a feedstock to produce biochemicals and bioplastics.
Question 4: The speed at which Giant King Grass matures as regrowth is astounding. What is the basis for this amazing increase in productivity in the second and succeeding years?
Answer: We at VIASPACE call Giant King Grass “the new biomass for green energy”. Giant King Grass is a very fast growing, high yield, hybrid grass that is neither genetically modified nor invasive. It grows in a variety of soil conditions and does not compete with food crops. Giant King Grass is perennial and it is a short rotation crop that can be harvested in the first year, compared to other crops that have much lower yields and cannot be harvested until their second, third or fourth year of growth. Regrowth is significantly faster than the initial harvest because the plant establishes an excellent root system. Once GKG has been established, it can be harvested at 3-5 feet tall for biogas production every 45 to 60 days. For other applications such as power plant fuel, pellets or biofuels, it is harvested at 13-16 feet tall every 150-180 days. This high rate of growth of GKG can provide a continual supply of biomass year-round. With competitive energy characteristics combined with multiple harvests per year, the energy output or energy yield of GKG per acre per year is much higher than other grasses. As a result, GKG cultivation offers material productivity benefits and therefore lower cost biomass for energy production, biofuels and biomaterials.
To view the rest of this transcript, visit http://dtg.fm/mUB1
For additional information on VIASPACE, visit www.VIASPACE.com
Viscount Systems, a leading-edge supplier of security systems and software, excitedly announced today that it will be securing its first set of U.S. Federal Government sites outside the continental USA. The systems will include Viscount’s Freedom Encryption Bridge technology as well as enrollment and revocation list software applications.
“We are very pleased to continue to build our relationship with U.S. Federal Government agencies and to expand the territorial coverage of the Freedom platform,” noted Stephen Pineau, President and CEO of Viscount. “For this and other pending projects we have also added CRL (certificate revocation list) software to our new enrollment platform, which creates additional savings for our agency customers. The cost advantages of Freedom and the fact that it is fully compliant with U.S. Government identity management/access control standards (FIPS 201-2 and HSPD-12), provides a compelling value proposition to government customers.”
At the request of the government, Viscount did not the nature of the facilities or the agency involved.
For more information, visit www.Viscount.com
International Stem Cell Corp., a California-based biotechnology company focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs), announced this morning that it will present results of pre-clinical studies of Parkinson’s disease (PD) at the 65th American Academy of Neurology Annual Meeting at the San Diego Convention Center, San Diego, California, on Wednesday, March 20th, 2013.
At the meeting Dr. Ruslan Semechkin, Vice President of Research and Development for ISCO, will present results from efficacy studies of stem cell derived neuronal cells for the treatment of Parkinson’s disease. Results and conclusions from both rodent and non-human primate models of the disease will be presented.
One of the world’s most important annual events for neurologists and neuroscience professionals, the American Academy of Neurology Annual Meeting is the largest international meeting of its kind with more than 12,000 attendees at last year’s meeting.
For more information, visit www.intlstemcell.com
Loans4Less.com, publicly traded online mortgage loan brokerage focused on becoming a national loan origination platform, announced certain audited financial results for the year ended December 31, 2012.
Total revenues for 2012 increased by approximately 64% compared to 2011. The company also reported the payoff of $98K in revolving debt from free cash flow, which made a significant improvement in Loan4Less.com’s balance sheet. According to today’s press release, the Annual Report 2012 will be posted in due course.
Loans4Less.com believes the mortgage origination market will stay very active this year even though lender underwriting standards are enabling only best credit quality borrowers to close on their loans. The current mortgage market mainly consists of Fannie Mae/Freddie Mac Conforming fixed rate refinancings.
Steven M. Hershman, Chairman & President, stated, “Purchase activity is gaining traction with mortgage rates still very low. Loans4Less.com sees highly favorable market conditions as a catalyst for ongoing significant improvement in our business growth and future expansion. We are developing an all-state mortgage loan origination platform for joint venture and/or licensing partners in order to brand and expose Loans4Less.com as a national site for loan products and earn revenues from these ventures.”
For more information, visit www.loans4less.com
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) to Provide 2013 Business Outlook on March 6, 2013
- Bergamo Acquisition Corp. (BGMO) Provides Authenticated Documentation to Confirm Bank Deposits
- Consorteum Holdings, Inc. (CSRH) Reaches Funding Agreement With Private Equity Group
- Cardium Therapeutics, Inc. (CXM) Announces Presentation at The 2013 Cell & Gene Therapy Forum
- Duma Energy Corp. (DUMA) Receives 1.1 Billion Barrel P10 Estimate for Namibia Concession
- GlobalWise Investments, Inc. (GWIV) CEO to Speak at Technology United Executive Conference
- HII Technologies, Inc. (HIIT) Announces Engagement of QualityStocks Investor Relations Services
- International Stem Cell Corp. (ISCO) to Present at 65th American Academy of Neurology Annual Meeting
- Loans4Less.com, Inc. (LFLS) Audited Financials 2012
- Rafarma Pharmaceuticals, Inc. (RAFA) Receives General License for Pharmaceutical Products Starts Mfg. 3 New Products
- Rainbow Coral Corp. (RBCC) Opens Talks to Help Develop Revolutionary Breakthrough in $60 Billion Drug Delivery Market
- The Guitammer Company Inc. (GTMM) Joins Nationwide, North America's Largest Buying and Marketing Organization
- Viaspace, Inc. (VSPC) Chairman Interviews with CEONEWS.Tv Regarding Business Dynamics and Recent Corporate Milestones
- Viscount Systems, Inc. (VSYS) Receives New U.S. Government Award
- VistaGen Therapeutics, Inc. (VSTA) Becomes Member of Centre for Commercialization of Regenerative Medicine Consortium